Cleared Traditional

K915457 - PHACO 20/20 SYSTEM I

K915457 is an FDA 510(k) clearance for PHACO 20/20 SYSTEM I, manufactured by Innovative Medical Systems, Inc.. The device is a Class 2 Ophthalmic device with product code HQC cleared through the Traditional 510(k) pathway after a 81-day FDA review.

K915457 · Innovative Medical Systems, Inc. · Ophthalmic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 1992
Decision
81d
Days
Class 2
Risk

K915457 is an FDA 510(k) clearance for the PHACO 20/20 SYSTEM I. Classified as Unit, Phacofragmentation (product code HQC), Class II - Special Controls.

Submitted by Innovative Medical Systems, Inc. (Commack, US). The FDA issued a Cleared decision on February 24, 1992 after a review of 81 days - a notably fast clearance cycle.

This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 886.4670 - the FDA ophthalmic device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Innovative Medical Systems, Inc. devices

FDA 510(k) Submission Details - K915457

510(k) Number K915457 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 05, 1991
Decision Date February 24, 1992
Days to Decision 81 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
29d faster than avg
Panel avg: 110d · This submission: 81d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

HQC Device Classification - Class 2, Special Controls

Product Code HQC Unit, Phacofragmentation
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 886.4670
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Ophthalmic devices follow this clearance model.

Regulatory Peers - HQC Unit, Phacofragmentation

All 194
Devices cleared under the same product code (HQC) and FDA review panel - the closest regulatory comparables to K915457.
IOLAB REUSABLE PERISTATIC CASSETTE/OPHTHALMIC USE
K921607 · Chiron Vision Corp. · Jun 1992
MENTOR ODYSSEY PHACOEMULSIFICATION SYSTEM
K912904 · Mentor O & O, Inc. · Jun 1992
IOLAB POWER I.V. POLE
K921135 · Site Microsurgical Systems, Inc. · Jun 1992
PHACO 3000 LINEAR
K915456 · Innovative Medical Systems, Inc. · Feb 1992
PHACO EMULSIFICATION,IRRIGATION/ASPIRATION TUBE
K915118 · Ipax, Inc. · Dec 1991
PHACOEMULSIFICATION SYSTEM FOR OPHTHALMIC USE
K912902 · Site Microsurgical Systems, Inc. · Dec 1991